FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022079004> ?p ?o ?g. }

• W2022079004 endingPage "e29492" @default.
• W2022079004 startingPage "e29492" @default.
• W2022079004 abstract "Interleukin-15 (IL-15) is thought to be involved in the physiopathological mechanisms of RA and it can be detected in the serum and the synovial fluid of inflamed joints in patients with RA but not in patients with osteoarthritis or other inflammatory joint diseases. Therefore, the objective of this work is to analyse whether serum IL-15 (sIL-15) levels serve as a biomarker of disease severity in patients with early arthritis (EA).Data from 190 patients in an EA register were analysed (77.2% female; median age 53 years; 6-month median disease duration at entry). Clinical and treatment information was recorded systematically, especially the prescription of disease modifying anti-rheumatic drugs. Two multivariate longitudinal analyses were performed with different dependent variables: 1) DAS28 and 2) a variable reflecting intensive treatment. Both included sIL-15 as predictive variable and other variables associated with disease severity, including rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPA). Of the 171 patients (638 visits analysed) completing the follow-up, 71% suffered rheumatoid arthritis and 29% were considered as undifferentiated arthritis. Elevated sIL-15 was detected in 29% of this population and this biomarker did not overlap extensively with RF or ACPA. High sIL-15 levels (β Coefficient [95% confidence interval]: 0.12 [0.06-0.18]; p<0.001) or ACPA (0.34 [0.01-0.67]; p = 0.044) were significantly and independently associated with a higher DAS28 during follow-up, after adjusting for confounding variables such as gender, age and treatment. In addition, those patients with elevated sIL-15 had a significantly higher risk of receiving intensive treatment (RR 1.78, 95% confidence interval 1.18-2.7; p = 0.007).Patients with EA displaying high baseline sIL-15 suffered a more severe disease and received more intensive treatment. Thus, sIL-15 may be a biomarker for patients that are candidates for early and more intensive treatment." @default.
• W2022079004 created "2016-06-24" @default.
• W2022079004 creator A5004363203 @default.
• W2022079004 creator A5009893459 @default.
• W2022079004 creator A5011908954 @default.
• W2022079004 creator A5012858626 @default.
• W2022079004 creator A5013670329 @default.
• W2022079004 creator A5021666977 @default.
• W2022079004 creator A5021896952 @default.
• W2022079004 creator A5032231697 @default.
• W2022079004 creator A5037738055 @default.
• W2022079004 creator A5058030577 @default.
• W2022079004 creator A5070756839 @default.
• W2022079004 creator A5072450048 @default.
• W2022079004 creator A5076189703 @default.
• W2022079004 creator A5087324345 @default.
• W2022079004 date "2011-12-29" @default.
• W2022079004 modified "2023-09-27" @default.
• W2022079004 title "Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis" @default.
• W2022079004 cites W1479829890 @default.
• W2022079004 cites W1553271826 @default.
• W2022079004 cites W1559643467 @default.
• W2022079004 cites W1739088794 @default.
• W2022079004 cites W1975573735 @default.
• W2022079004 cites W1976262436 @default.
• W2022079004 cites W1982974870 @default.
• W2022079004 cites W1986526577 @default.
• W2022079004 cites W1994955099 @default.
• W2022079004 cites W1995276823 @default.
• W2022079004 cites W1995288662 @default.
• W2022079004 cites W1999709426 @default.
• W2022079004 cites W2006073656 @default.
• W2022079004 cites W2015360645 @default.
• W2022079004 cites W2026398322 @default.
• W2022079004 cites W2034291817 @default.
• W2022079004 cites W2035591424 @default.
• W2022079004 cites W2046677065 @default.
• W2022079004 cites W2051638547 @default.
• W2022079004 cites W2069028348 @default.
• W2022079004 cites W2072117604 @default.
• W2022079004 cites W2072857434 @default.
• W2022079004 cites W2073006623 @default.
• W2022079004 cites W2077384389 @default.
• W2022079004 cites W2099229060 @default.
• W2022079004 cites W2106836193 @default.
• W2022079004 cites W2110177517 @default.
• W2022079004 cites W2136930502 @default.
• W2022079004 cites W2147920824 @default.
• W2022079004 cites W2152348310 @default.
• W2022079004 cites W2157383616 @default.
• W2022079004 cites W2169845280 @default.
• W2022079004 cites W2763284518 @default.
• W2022079004 cites W4211172841 @default.
• W2022079004 cites W4313343453 @default.
• W2022079004 doi "https://doi.org/10.1371/journal.pone.0029492" @default.
• W2022079004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3248461" @default.
• W2022079004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22242124" @default.
• W2022079004 hasPublicationYear "2011" @default.
• W2022079004 type Work @default.
• W2022079004 sameAs 2022079004 @default.
• W2022079004 citedByCount "56" @default.
• W2022079004 countsByYear W20220790042012 @default.
• W2022079004 countsByYear W20220790042013 @default.
• W2022079004 countsByYear W20220790042014 @default.
• W2022079004 countsByYear W20220790042015 @default.
• W2022079004 countsByYear W20220790042016 @default.
• W2022079004 countsByYear W20220790042017 @default.
• W2022079004 countsByYear W20220790042018 @default.
• W2022079004 countsByYear W20220790042019 @default.
• W2022079004 countsByYear W20220790042020 @default.
• W2022079004 countsByYear W20220790042021 @default.
• W2022079004 countsByYear W20220790042022 @default.
• W2022079004 crossrefType "journal-article" @default.
• W2022079004 hasAuthorship W2022079004A5004363203 @default.
• W2022079004 hasAuthorship W2022079004A5009893459 @default.
• W2022079004 hasAuthorship W2022079004A5011908954 @default.
• W2022079004 hasAuthorship W2022079004A5012858626 @default.
• W2022079004 hasAuthorship W2022079004A5013670329 @default.
• W2022079004 hasAuthorship W2022079004A5021666977 @default.
• W2022079004 hasAuthorship W2022079004A5021896952 @default.
• W2022079004 hasAuthorship W2022079004A5032231697 @default.
• W2022079004 hasAuthorship W2022079004A5037738055 @default.
• W2022079004 hasAuthorship W2022079004A5058030577 @default.
• W2022079004 hasAuthorship W2022079004A5070756839 @default.
• W2022079004 hasAuthorship W2022079004A5072450048 @default.
• W2022079004 hasAuthorship W2022079004A5076189703 @default.
• W2022079004 hasAuthorship W2022079004A5087324345 @default.
• W2022079004 hasBestOaLocation W20220790041 @default.
• W2022079004 hasConcept C126322002 @default.
• W2022079004 hasConcept C142724271 @default.
• W2022079004 hasConcept C185592680 @default.
• W2022079004 hasConcept C203014093 @default.
• W2022079004 hasConcept C204787440 @default.
• W2022079004 hasConcept C2776164576 @default.
• W2022079004 hasConcept C2776232647 @default.
• W2022079004 hasConcept C2777077863 @default.
• W2022079004 hasConcept C2777575956 @default.
• W2022079004 hasConcept C2779134260 @default.

• next